Urinary bile acids from 20 patients treated with chenodeoxycholate, 18 treated with ursodeoxycholate, 15 treated with rifampicin and 8 patients with advanced cirrhosis were analyzed by gas-liquid chromatography and gas-liquid chromatography-mass spectrometry. Occurrence rates and amounts of three so
A paucity of unusual trihydroxy bile acids in the urine of patients with severe liver diseases
โ Scribed by Toshiaki Nakashima; Yoshikuni Sakamoto; Koji Inaba; Hironori Mitsuyoshi; Hiroki Ishikawa; Yoshiki Nakajima; Motonari Sakai; Toshihide Shima; Kei Kashima
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 81 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
To clarify the relationship between the occurrence of unusual trihydroxy bile acids, namely hyocholic acid, ursocholic acid (UCA), and omega-muricholic acid (omega-MCA) in urine and liver disease severity, urinary bile acids were analyzed by gas-liquid chromatography in acute and late phases of acute hepatitis and before and after ursodeoxycholic acid (UDCA) loading in healthy adults and liver cirrhosis patients. In 11 patients with acute hepatitis, the occurrence rates and amounts of unusual trihydroxy bile acids were increased in the late (recovery) phase, as compared with those in the early phase. In 10 patients with severe acute hepatitis who had prothrombin times exceeding 16 seconds, these bile acids had completely disappeared from the urine in the early phase but reappeared in the late phase in those who had a good outcome, though never in a patient who died. After UDCA administration for a week, the amounts of unusual bile acids, especially UCA and omega-MCA, which are thought to be synthesized through 12 alpha- and 6 alpha-hydroxylations, respectively, from UDCA, were clearly increased in 10 healthy adults but only slightly changed in 10 patients with liver cirrhosis. In conclusion, hepatic hydroxylations of dihydroxy bile acids as a detoxification reaction were impaired in severe liver diseases, which may play a role in the intensification and perpetuation of hepatocellular injuries.
๐ SIMILAR VOLUMES
The significance of cysteinyl leukotrienes was investigated in patients with liver diseases by measurements of leukotriene E, andN-acetyl-leukotriene E, in urine. A marked increase of renal cysteinyl leukotriene excretion was observed in patients with cirrhosis without and with ascites, intrahepatic
The meta-analysis of propranolol compared with endoscopic variceal ligation for primary prophylaxis of variceal bleeding by Imperiale and Chalasani 1 favors pharmacotherapy despite the fact that "none of the trials measured the hemodynamic response to propranolol." "Blind beta blockade" is the admin
Mayo risk score, United Network for Organ Sharing (UNOS) status, Organ Sharing.
To investigate the prevalence and incidence of cholecystolithiasis in hepatitis B surface antigen-positive chronic liver diseases, a prospective study using hepatobiliary ultrasonography was conducted in 933 "healthy" persons and four groups of HBsAg-positive patients: 226 asymptomatic carriers, 73